Open access

Up-to-Date Insight About Membrane Remodeling as a Mechanism of Action for Ethanol-Induced Liver Toxicity

Written By

Odile Sergent, Fatiha Djoudi-Aliche and Dominique Lagadic-Gossmann

Submitted: 17 February 2011 Published: 11 January 2012

DOI: 10.5772/27410

From the Edited Volume

Trends in Alcoholic Liver Disease Research - Clinical and Scientific Aspects

Edited by Ichiro Shimizu

Chapter metrics overview

3,222 Chapter Downloads

View Full Metrics

1. Introduction

Hepatocellular death is a key mechanism in alcoholic liver diseases. Although ethanol has been described for many years as capable of increasing membrane fluidity, it is only recently that this fluidizing effect has been reported to be involved in ethanol-induced liver toxicity. In addition, in the last decade, a better understanding of plasma membrane has led to suggest that this membrane is not a random association of lipids, but is rather heterogeneous, with various microstructures enriched in specific components depending on their affinity. Special attention has been paid on lipid rafts that are cholesterol- and sphingolipid- rich microstructures, conferring them higher rigidity compared to other plasma membrane microdomains. As lipid rafts can also activate or suppress cell signaling pathways, lipid raft discovery provides new arguments for several researchers to revisit the fluidizing effect of ethanol by studying the possible ethanol-induced physical and biochemical alteration of lipid rafts. Thus, in this chapter, we have considered to review the capacity of ethanol to induce a membrane remodeling, depicted as an increase in membrane fluidity and alterations of physical and biochemical properties of lipid rafts, and its relationship with ethanol liver toxicity.


2. Membrane fluidity

The Singer-Nicolson fluid mosaic model indicates that membranes consist of a phospholipid bilayer, where lipids, in a fluid phase, act as solvent for proteins (Singer & Nicolson, 1972). In this chapter, membrane fluidity means the relative freedom of motion for membrane components, especially phospholipids, and represents the combination of various types of mobility (Figure 1). Membrane fluidity is principally determined by the acyl chain swinging movement and phospholipid rotation. Thus, short chains and double bonds in acyl chains of phospholipids create spaces in the bilayer and promote membrane fluidization. At the opposite, the rigid steroid nucleus of cholesterol, lying next to the first 9 or 10 carbon atoms of the phospholipid acyl chains, prevents the swinging movement of the acyl chains thereby stiffening membranes. For the evaluation of this membrane parameter, most studies have used either electron paramagnetic resonance (EPR) with spin-labeled fatty acids, or polarization of fluorescence with hydrophobic fluorescence polarization probes. An increased membrane fluidity for EPR is usually assessed by a decrease of order parameter (S), and for fluorescence, by a decrease of polarization (P), anisotropy (A) or microviscosity (η).

Figure 1.

Different types of mobility of phospholipids.

Any alteration of the optimal range for membrane fluidity has influenceon many biological functions such as membrane enzyme and receptor activities, or transmembrane transport processes (Ho et al, 1994; Schachter, 1984; Stubbs et al, 1988). Furthermore, more recently, it was also shown its fundamental role in cell signalling responses to xenobiotic stress (polycyclic aromatichydrocarbons, cisplatin or ethanol), leading to cell death such as apoptosis (Rebillard et al, 2007; Sergent et al, 2005; Tekpli et al, 2011).

2.1. Plasma liver membranes

Since the end of the seventies, many papers have provided strong evidence that ethanol very rapidly induces a fluidization of membranes as reported by several reviews (Goldstein, 1987; Rottenberg, 1992;Wood & Schroeder, 1988).

2.1.1. Tissue type-dependent effect of ethanol

Using electron paramagnetic resonance, Chin and Goldstein (1977a) were the first to demonstrate the ability of ethanol used at low concentrations (from 20 mM - 40 mM) to increase in vitro membrane fluidity of erythrocyte and synaptosomal plasma membranes. In addition, they showed that continuous exposure of mice to ethanol provided in the diet for a short period (8 days) (Chin & Goldstein, 1977b) or by inhalation (3 days) (Lyon & Goldstein, 1983) respectively restored a membrane fluidity near controls or even rigidified membranes in the inner hydrophobic regions, testifying an adaptation. Thus, in alcoholic patients, erythrocytes exhibited a decrease in membrane fluidity (Beaugé et al, 1985; Parmahamsa et al, 2004). However, the effect of ethanol on plasma membranes is different for the liver. Indeed, they become more fluid, mainly in the inner hydrophobic regions, for chronically ethanol-intoxicated rats (Schüller et al, 1984; Yamada &Lieber, 1984) and an increase in fluidity was also observed in plasma membranes isolated from Reuber H35 rat hepatomacells (Polokoff et al, 1985) or WRL-68 human hepatic cells (Gutierrez-Ruiz et al, 1995) following a long term treatment with ethanol (3 or 4 weeks). Such an effect could contribute to the special sensitivity of liver to ethanol toxicity. At the opposite, other organelles in the liver did not exhibit any membrane fluidification after ethanol intoxication of rats (Table 1).It should be noted that, when primary hepatocytes isolated from chronically ethanol-treated rats were cultured before the evaluation of plasma membrane fluidity by fluorescence polarization, an increased ordering was observed (Benedetti et al, 1994).

Table 1.

Effect of chronic ethanol intoxication on membrane fluidity of various organellesin the liver.(In all experiments, rats were fed a diet containing 36 % of total calories as ethanol for 30 to 40 days.)

Whatever exposure modes (ingestion, inhalation or intraperitoneal injections) (Chin &Golstein, 1977b; Lyon &Golstein, 1983; Johnson et al, 1979), erythrocyte and synaptosomal plasma membranes isolated from ethanol-treated mice did not exhibit an increase in membrane fluidity after a further in vitro ethanol addition in contrast to membranes isolated from untreated mice. Such an in vitro resistance was also observed in erythrocyte membranes from alcoholic patients (Beaugé et al, 1985). Even though liver plasma membranes remained more fluid after chronic rat intoxication (Schüller et al, 1984; Yamada &Lieber, 1984) or after long term ethanol treatment of cultured hepatocytes (Gutierrez-Ruiz et al, 1995; Polokoff et al, 1985), these isolated membranes also exhibited an in vitro resistance to the disordering effect of a further direct addition of ethanol. Finally, most of the papers quoted in table 1 indicated such a process for microsomes or mitochondria. This phenomenomcould be related to several changes in membrane lipid composition (Johnson et al, 1979) ie an increase in cholesterol within brain and liver cell membranes in rats (Chin et al, 1978) and in monkeys (Cunningham et al, 1983), an increased ratio of saturated to polyunsaturated fatty acids (Johnson et al, 1979), or reduced concentrations of sialic acid and galactose in the membrane surface of human erythrocytes (Beaugé et al, 1985).

2.1.2. Molecular mechanisms whereby ethanol could increase membrane fluidity

These mechanisms, summarized in figure 2, can occur simultaneously. The first described mechanism was in brain membranes and concerns physical properties of ethanol which allow it to directly interact with the lipid bilayer, thus triggering a direct membrane disorder (Goldstein, 1984; Gurtovenko& Anwar, 2009; Marquês et al, 2011; Rottenberg, 1992). This theory was particularly developed in the field of drug tolerance and physical dependence, but, in the liver, other mechanisms were also described. First, it was proposed that the fluidizing effect of chronic ethanol treatment could be related to changes in membrane lipid composition as acyl chain saturation and cholesterol are well-described to affect membrane fluidity. Thus, Yamada et al (1984) related the increase in membrane fluidity of liver plasma membranes after chronic ethanol feeding to a decrease in cholesterol plasma membrane content by an unknown mechanism. In hepatoma cells chronically exposed to ethanol for 3 weeks, the increase in membrane fluidity of plasma membranes was linked to the elevation of the ratio phosphatidylcholine/sphingomyelin (Polokoff et al, 1985). However, the main distinction of liver is that most of the ethanol metabolism occurs in this organ. Thus, ethanol metabolism appeared to play a key role since blocking ethanol metabolism by methylpyrazole inhibited changes in membrane fluidity both in acute intoxicated primary rat hepatocytes (Sergent et al, 2005), and in chronically treated hepatoma cells (Polokoff et al, 1985). Logically, as ethanol metabolism was involved, our team was interested in looking at the involvement of oxidative stress following an acute ethanol intoxication of primary rat hepatocytes. Using antioxidant such as thiourea (reactive oxygen species (ROS) scavenger) or vitamin E (lipid peroxidation inhibitor), we showed that oxidative stress played a role in the fluidizing effect of ethanol (Sergent et al, 2005). This new mechanism explained how ethanol could very rapidly (30 minutes) increase membrane fluidity since ROS production could be detected as soon as 15 minutes. Several molecular mechanisms can be proposed to explain the influence of oxidative stress on membrane fluidity. First, lipid peroxidation by-products could increase membrane fluidity either by interacting with membrane proteins (Buko et al, 1996; Subramaniam et al, 1997), or more directly by their own rearrangement (Jain et al, 1994;Gabbita et al, 1998). ROS, by oxidizing tubulin could also disrupt microtubule cytoskeleton, thereby increasing membrane fluidity (Yoon et al, 1998; Remy-Kristensen et al, 2000). In our model of primary rat hepatocytes, paclitaxel (a microtubule stabilizer) prevented from the fluidizing effect of ethanol (unpublished data).

Figure 2.

(ROS : reactive oxygen species).

Possible molecular mechanisms for ethanol to increase membrane fluidity.

2.2. Liver mitochondria membranes

As shown above, a great body of evidence indicated that, in inner membranes of mitochondria, ethanol intoxication induced a decrease rather than an increase in fluidity. This was demonstrated for chronically intoxicated rats but also with HepG2 human hepatocytes treated with acetaldehyde, a product of ethanol metabolism (Lluis et al, 2003), providing a further proof of the involvement of ethanol metabolism in membrane fluidity changes. In addition, this decrease was related to an elevation of cholesterol content in mitochondria which concerns both outer and inner membranes. Finally, the acetaldehyde stimulation of cholesterol incorporation into mitochondria membranes was attributed to endothelium reticulum stress.

2.3. Membrane pharmacology of ethanol liver toxicity by manipulation of membrane fluidity

Since the eighties, many studies suggested the influence of ethanol fluidizing effect on membrane protein activities (McCall et al, 1989; Mills et al, 1985;Rubin &Rottenberg, 1982). Only recently, researchers became interested in determining the role of membrane fluidity changes in ethanol-induced hepatocellular death. Thus, manipulation of plasma membrane fluidity by exposing primary rat hepatocytes to membrane stabilizing agents (ursodeoxycholic acid (UDCA) or ganglioside GM1 (GM1)) led to the inhibition of ethanol-induced cell death, while fluidizing compounds (tween 20 or A2C) enhanced it (Sergent et al, 2005). In order to explain how plasma membrane fluidity could affect cell death, oxidative stress was also studied. At the opposite of fluidizing compounds, membrane stabilizing agents were shown to protect from ethanol-induced lipid peroxidation, ROS production and the elevation of another prooxidant factor, namely low-molecular-weight iron. Low-molecular-weight iron consists of iron species that can trigger oxidative stress by catalyzing the formation of a highly reactive free radical, the hydroxyl radical.It should be noted that UDCA and GM1 displayed a protection towards ethanol-induced ROS production only when ROS were evaluated after 1 or 5 hours of incubation with ethanol. At 15 minutes, no protection was afforded by membrane stabilizing agents, unlike the inhibitor of ethanol metabolism, 4-methyl-pyrazole. This led us to postulate a sequence of events whereby the early ROS formation was mainly due to ethanol metabolism and the late phase to the increase in membrane fluidity (Figure 3). Interestingly, the increased mitochondrial membrane ordering was also associated with the development of oxidative stress. Indeed, stabilizing agents such as S-adenosyl-L methionine (SAME) or taurine conjugate of UDCA (tauroursodeoxycholic acid) protected from glutathione depletion in mitochondria obtained from the liver of rats chronically fed with ethanol (Colell et al, 1997; Colell et al, 2001). Reduced glutathione, the main non protein thiol in cells, plays an important role to detoxify hydrogen peroxide and other organic peroxides in mitochondria. Glutathione depletion in mitochondria made them more sensitive to ROS production and subsequent oxidative stress. Thus, it was demonstrated that the increased mitochondrial membrane microviscosity impaired the glutathione transporter which normally allows the glutathione transport from cytosol to mitochondrial matrix (Coll, 2003; Lluis et al, 2003) (Figure 3).

Figure 3.

(GSH : reduced glutathione; ROS : reactive oxygen species).

Relationship between membrane fluidity and ethanol-induced oxidative stress.

Cholesterol involvement in this process should be pointed out. Indeed, as mitochondrial membrane enrichment in cholesterol was responsible for the decreased mitochondrial membrane fluidity, lovastatin, an inhibitor of hydroxymethylglutaryl coenzyme A involved in cholesterol synthesis, was able to protect hepatocytes from acetaldehyde sensitization to tumor necrosis factor (TNF)α (Lluis et al, 2003). Similarly to membrane stabilizing agents, membrane fluidizer (A2C) restored the initial glutathione transport rate and mitochondrial content (Coll et al, 2003; Lluis et al, 2003). However, the use of membrane fluidizers should be done with caution since, from our results about the involvement of plasma membrane fluidization in ethanol-induced cell death, it appears that they can be injurious for hepatocytes. At the opposite, UDCA and its conjugates seem to be good candidates for a potential therapeutic use, because, due to their membrane stabilizing properties (Güldütuna et al, 1993), they restore the normality in membrane fluidity for every type of membranes. Thus, in case of ethanol intoxication, they were able to prevent both the increase of plasma membrane fluidity, as we observed in primary rat hepatocytes (Sergent, 2005), and the decrease in mitochondria membranes of hepatocytes from ethanol-fed rats (Colell et al, 2001). In addition, UDCA was also shown to protect rats from the increase in liver plasma membrane fluidity due to chronic ethanol intake and hence from liver lipid peroxidation and necrosis (Oliva et al, 1998). However, although UDCA is a therapeutically relevant bile acid, already used for preventing human primary biliary cirrhosis (Poupon et al, 2003; Corpechot et al, 2011), it did not exhibit any beneficial effect on a 6-month survival of patients with severe alcohol-induced cirrhosis, but possibly because of inappropriate dosage (Pelletier et al, 2003).


3. Lipid rafts

Because of the well-described effect of ethanol on plasma membrane fluidity, it is not surprising that some researchers about alcoholic liver diseases were interested in the possible involvement of lipid rafts in ethanol toxicity. Indeed, plasma membrane is not constituted by a random lipid distribution but rather by a selective lateral lipid segregation due to self-associative properties of sphingolipid and cholesterol, leading to the concept of "lipid rafts" (Simons &Toomre, 2000; Lingwood& Simons, 2010). Thus, lipid rafts are detergent-resistant, sphingolipid- and cholesterol-rich microdomains of the plasma membrane, which form highly ordered spatial nanoscaleassemblies separated from other membrane regions composed of more unsaturated and loosely packed fatty acids (Figure 4).

Figure 4.

Schematic representation of a lipid raft (without proteins).

Lipid rafts as nanoscale assemblies are dynamics and after cell stimulation, can coalesced to larger levels to form raft platforms (Harder &Engelhardt, 2004). Concerning proteins, lipid rafts are notably enriched in glycosylphosphatidylinositol (GPI) proteins, receptors such as cell death receptorsand Toll-like receptors (TLR), and signaling proteins like mitogen-activating protein kinases, protein kinases C etc. Some proteins are raft residents, whereas others are recruited after cell stimulation with receptor-specific ligands. In addition, based on their mobility, lipid rafts, through their aggregation, can form platforms that assembly many proteins on a same place leading to the formation of a receptor cluster, which can then activate or suppress signaling pathways (Pike, 2003; Schmitz &Orso, 2002).One might suppose that ethanol, through its capacity to increase liver plasma membrane fluidity, can disturb these microdomains and hence, various cell signaling pathways. Consequently, in the last past decade, new investigations were undertaken to possibly link lipid rafts to ethanol toxicity. Researches were conducted in two directions: the main one concerned perturbation of innate immunity via TLR4 signaling and the other one, hepatocyte cell death via the activation of phospholipase C (PLC) signaling.

3.1. Lipid rafts in the TLR4 signaling dysfunction by ethanol

Several components of innate immunity contribute to the pathogenesis of alcoholic liver disease (Gao et al, 2011). Here, we will mainly focus on lipopolysaccharide (LPS)/TLR4 signaling pathways because of the necessary translocation of TLR4 receptor into lipid rafts for its activation.

3.1.1. Involvement of LPS/TLR4 signaling pathway in alcoholic liver disease

Strong evidence suggest that the immune cells of the liver (phagocytic cells such as neutrophils or resident Küpffer cells, and lymphocytes such as natural killer [NK] cells or T cells) play a crucial role in alcoholic liver disease including steatosis, hepatitis and fibrosis (Suh&Jeong, 2011). Thus, Küpffer cells are main actors in the immune response against endotoxin/lipopolysaccharide (LPS) via Toll-Like Receptor type 4 (TLR4) signaling pathway leading to the production of pro-inflammatory mediators such as cytokines (TNF-α, interleukin [IL]-1, IL-6), chemokines (monocyte chemotactic protein-1 [MCP-1]), ROS and profibrogenic factors (transforming growth factor [TGF]-β, platelet-derived growth factor [PDGF]), which subsequently activate hepatic stellate cells for the production of extracellular matrix (Jeong&Gao, 2008) (Gao et al, 2011) (Figure 5). Indeed, it is well established that ethanol intake, by increasing gut permeabilization, allows the uptake of LPS in portal circulation (Parlesak et al, 2000) promoting liver ethanol toxicity (Nanji et al, 1994). In addition, in the liver, TLR4 is also expressed on recruited macrophages, hepatocytes, sinusoidal endothelial cells and hepatic stellate cells (Seki & Brenner, 2008). Consequently, via TLR4 signalling, these last cells can also contribute to liver inflammation by releasing proinflammatory cytokines and chemokines. Finally, TLR4 signalling in hepatic stellate cells can also participate to the development of alcoholic fibrosis by enhancing TGF-β signalling (Seki et al, 2007). Therefore, TLR4 receptor appeared crucial in the development of alcoholic liver disease (Gao et al, 2011).

Figure 5.

(HEP : hepatocytes; HSC: hepatic stellate cells; KC : Küpffer cells; IL : interleukin; LPS : lipopolysaccharide; MCP-1 : monocyte chemotactic protein-1 ; PDGF : platelet-derived growth factor; TGF: tumor growth factor; TLR4 : Toll-like receptor 4; TNF : tumor necrosis factor)

Contribution of TLR4 receptor to the pathogenesis of alcoholic liver disease.

3.1.2. Effects of ethanol on the recruitment of TLR4 into lipid rafts

LPS does not bind TLR4 receptor directly, but is rather first bound to cell surface co-receptors, the cluster of differentiation 14 (CD14) and the myeloid differentiation protein 2 (MD-2), without cytoplasmic domains (Fitzgerald, 2004). However, TLR4 is the integrator of cell signalling since it has intracellular signaling domains. Close interactions between these membrane receptors are made possible by their recruitment and assembly within lipid rafts (Schmitz &Orso, 2002; Triantafilou et al, 2002). Thus, CD14 is a glycosyl phosphatidylinositol-linked protein which therefore constitutively resides in lipid rafts, while TLR4 needs translocation into rafts for the complex formation (Dolganiuc et al, 2006). Two features of the ethanol effect on TLR4 and other receptor signaling could be distinguished depending on ethanol concentration.

  1. At high concentration (≥ 50 mM), ethanol prevented from LPS-induced redistribution pattern of the co-receptor CD14 within lipid rafts, and from the translocation of TLR4 receptor into rafts (Table 2). This alteration could partly explain why ethanol consumption is recognized as a risk factor for concomitant bacterial or viral infections (Nelson and Kolls, 2002; Szabo, 1999). Dai et al (2005) and Dolganiuc et al (2006) suggested that ethanol, at the concentration of 50 or 86 mM, may disrupt lipid rafts because similar effects were obtained with lipid raft disrupters. However, a protein raft marker, flotillin did not exhibit any alteration and no clear evidence of lipid raft disruption was given, since the cholesterol decrease was detected in culture media instead of lipid rafts. They also attributed changes in partitioning cellular membrane in raft and nonraft structures to the increase in bulk membrane fluidity (Dolganiuc et al, 2006) without checking this influence by the use of membrane stabilizing agents or measuring the increase in membrane fluidity directly in lipid rafts. Their hypothesis would be that ethanol by this way could disrupt lipid protein interactions (Szabo et al, 2007). Only at very high concentrations (200 mM), a lipid raft disruption was really observed in RAW 264.7 macrophages (Fernandez-Lizarbe et al, 2008). However, at 50 mM, in primary rat cortical astrocytes, a partial disruption of lipid raft could be detected suggesting that ethanol at this concentration induced both effects :

  2. At lower concentration (≤ 50 mM), mimicking LPS effects both in macrophages and astrocytes, ethanol induced the recruitment of TLR4 into lipid rafts, thus allowing the activation of TLR4 dependent cell signalling (Table 2). A similar process was also observed for IL-1R1 (IL1 receptor 1) (Blanco et al, 2008). Thus, ethanol triggered cytokine and other inflammatory mediator secretion via lipid raft-dependent signalling pathway. According to Blanco et al (2008), low ethanol concentrations (10 – 50 mM) may facilitate protein-protein and protein-lipid interactions within the membrane microdomains to promote receptor recruitment into the lipid rafts. Even if this effect has not yet been directly described in the liver,lipid rafts might participate to the mechanisms involved in the enhancement by chronic ethanol treatment of liver inflammation associated with the activation of IL-1R1 receptor in rat liver and hepatocytes (Valles et al, 2003), or TLR4 in immune cells ( Szabo&Bala, 2010).

Table 2.

(ERK : extracellular regulated kinase; IL : interleukin; IRAK : interleukin-1 receptor associated kinase; LAT : linker for activation of T cells; lck : lymphocyte-specific protein tyrosine kinase; LPS : lipopolysaccharide; NF-kB : nuclear factor kappa B; PHA : phytohaemagglutinin; PLC: phospholipase C; TCR : T cell receptor; TNF : tumor necrosis factor).

Effects of acute ethanol exposure on lipid raft-mediated receptor activation.(In these studies, rafts were isolated by their in vitro property to resist to solubilization in non-ionic detergents at low temperature and to float and concentrate in low-density sucrose (Brown & Rose, 1992), leading to raft and non-raft fractions.)

3.2. Lipid rafts in ethanol-induced hepatocyte damage

Another approach was to consider the role of lipid rafts in ethanol-induced oxidative stress. The occurrence of oxidative stress in alcoholic liver disease and its relationship with ethanol liver damage have been extensively documented (Albano, 2008; Cederbaum et al, 2009; De Minicis& Brenner, 2008; Wu &Cederbaum, 2009), but less is known about the possible role of lipid rafts. Thus, it was shown by our team that lipid raft disrupters were able to protect from ethanol-induced ROS production and lipid peroxidation in primary rat hepatocytes (Nourissat et al, 2008). In addition, we have showed for the first time that oxidative changes within lipid rafts are a prerequisite for the oxidative stress to develop in rat hepatocytes. Thus, ethanol metabolism,by producing a rapid and mild oxidative stress, was able to induce oxidative damage within lipid rafts leading to their clustering following protein crosslinkages (Figure 6).

Figure 6.

(CHO : carbonyl group; ROS : reactive oxygen species; SH : thiol group)

Ethanol-induced lipid raft clustering via oxidative stress and protein crosslinkage.

Protein crosslinkages were obtained by the formation of disulfide bridges from two intermolecular thiol (SH) groups from several rafts, and by the formation of adducts with malondialdehyde, a well-known product of lipid peroxidation in ethanol treated-rat hepatocytes (Nourissat et al, 2008). This aldehyde like 4-hydroxynonenal can react with nucleophile residues in proteins to form carbonyl groups which then may form Schiff base with a lysine of another protein. Such a protein can be included in another raft leading to raft clustering (Figure 6). Interestingly, according to experiments performed on the translocation of TLR4 (see above) which proposed a role for membrane fluidity without fully demonstrating it, we expressly proved the involvement of the fluidizing effect in the ethanol-induced lipid raft clustering by the use of membrane stabilizer or fluidizers. In addition, ethanol was shown to be able to fluidize lipid rafts, but at a lesser extent compared to bulk membranes. These results also confirmed our previous results which showed the pivotal role of the increased membrane fluidity in ethanol-induced cell death of rat hepatocytes (Sergent et al, 2005), thereby emphasizing on the contribution of membrane remodeling in ethanol liver toxicity. Finally, lipid raft clustering also participated to the activation of phospholipase C-γ-dependent signaling pathway. Indeed, this clustering induced translocation of phospholipase C-γ into rafts, which induced elevation of low-molecular-weight-iron, a potent prooxidant factor, and hence, lipid peroxidation. To summarize, ethanol metabolism, by producing a mild oxidative stress can rapidly affect both membrane fluidity and lipid rafts, thus promoting lipid raft aggregation (Figure 7). Then, this lipid raft clustering, by activating phospholipase C-γ dependent signaling pathway, may in turn trigger amplification of oxidative stress and cell death (Figure 7).

Figure 7.

(LMW iron: low molecular weight iron; PLC: phospholipase C)

Amplification of oxidative stress via lipid raft clustering during acute ethanol intoxication of rat hepatocytes.

In this context, new therapeutic approach, called membrane lipid therapy (Escriba et al, 2006), could be a very effective strategy to protect hepatocytes from membrane-dependent oxidative damage in alcoholic liver damage, especially as an increasing body of evidence indicated that some dietary compounds such as plant flavonoids (Tarahosky et al, 2008) or fatty fish long-chain polyunsaturated n-3 fatty acids (n-3 PUFAs) (Wassal& Stillwell, 2009) might modify physical and chemical properties of lipid rafts. Thus, n-3 PUFAs have been extensively described as efficient modifiers of lipid and protein composition of lipid rafts in many cell types such as T lymphocytes (Fan et al, 2004; Stulnig, 2001), Caco-2 cells (Duraisamy et al, 2007), retinal vascular endothelial cells (Chen et al, 2007) and macrophages (Wong et al, 2009). In this context, the nutrional significance of lipid rafts has been recently pointed out (Yaqoob and Shaikh, 2010).


4. Conclusion

Taken altogether, these studies show that physical alterations of membranes (changes in membrane fluidity and microstructures) can be considered as an additional mechanism involved in ethanol liver toxicity. It is only in the last past decade that membrane remodeling appeared to be linked to ethanol liver toxicity (Figure 8). Therefore, further studies are needed in order to determine the role of lipid rafts in chronic ethanol intoxication, to further explore the downstream cell signaling after lipid raft clustering such as pathways involved in the elevation of low-molecular weight iron cell content, or to understand whether receptor recruitment in lipid raft might participate to alcoholic liver disease. In addition, other investigation should shed light on the possible beneficial effect of the modulation of membrane fluidity and lipid raft. Thus, statins that are already currently used in patients suffering from hypercholesterolemia, have demonstrated their efficiency to protect hepatocytes from acetaldehyde sentization to TNF (Lluis et al, 2003), and might also be proposed to disrupt lipid rafts. Finally, nutritional compounds such as plant flavonoids or fatty fish long-chain polyunsaturated n-3 fatty acids might represent a new therapeutic approach for patients with alcoholic liver disease based upon modulation of the membrane structures.

Figure 8.

Evolution of the "membrane remodelling" concept for alcoholic liver diseases.



The authors gratefully acknowledge IREB (Institut de RecherchesScientifiquessur les Boissons, Paris, France) for its financial support. They also wish to thank "Région Bretagne", which provided a grant for FatihaDjoudi. The authors are also very grateful to Martine Chevanne for her skilfull technical assistance.


  1. 1. Albano E. 2008 Oxidative mechanisms in the pathogenesis of alcoholic liver disease Molecular Aspects of Medicine 29 1-2 9 16 0098-2997
  2. 2. Aloia R. C. Paxton J. Daviau J. S. Van Gelb O. Mekusch W. Truppe W. Meyer J. A. . Brauer F. S. 1985 Effect of chronic alcohol consumption on rat brain microsome lipid composition membrane fluidity and Na+-K+-ATPase activity Life Sciences 36 10 1003 1017 0024-3205
  3. 3. Beaugé F. Stibler H. Borg S. 1985 Abnormal fluidity and surface carbohydrate content of the erythrocyte membrane in alcoholic patients. Alcoholism: Clinical and Experimental Research 9 4 322 326 0145-6008
  4. 4. Benedetti A. Tangorra A. Baroni G. S. Ferretti G. Marucci L. Jezequel A. M. . Orlandi F. 1994 Plasma membrane order parameter in periportal and perivenular hepatocytes isolated from ethanol-treated rats. American Journal of Physiology 266 2Pt1 G282 G291 0193-1857
  5. 5. Blanco A. M. Perez-Arago A. Fernandez-Lizarbe S. . Guerri C. 2008 Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells Journal of Neurochemistry 106 2 625 639 0022-3042
  6. 6. Brown D. A. Rose J. K. 1992.Sorting of GPI-anchored proteins to glycol-lipid enriched membrane subdomains during transport to the apical cell surface Cell 68 3 533 544 0092-8674
  7. 7. Buko V. Artsukevich A. Zavodnik I. Maltsev A. Suhko L. Zimmermann T. . Dianzani M. U. 1996 Interactions of malondialdehyde and 4-hydroxynonenal with rat liver plasma membranes and their effect on binding of prostaglandin E2 by specific receptors Free Radical Research, 25 5 415 420 1071-5762
  8. 8. Castro J. Cortés J. P. Guzman M. 1991 Properties of the mitochondrial membrane and carnitinepalmitoyltransferase in the periportal and the perivenous zone of the liver. Effects of chronic ethanol feeding Biochemical Pharmacology 41 12 1987 1995 0006-2952
  9. 9. Cederbaum A. I. Lu Y. Wu D. 2009 Role of oxidative stress in alcohol-induced liver injury Archives in Toxicology 83 6 519 548 0340-5761
  10. 10. Chen W. Jump D. B. Esselman W. J. Busik J. V. 2007 Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Investigative Ophtalmology and Visual Science 48 1 18 26 0146-0404
  11. 11. Chin J. H. Goldstein D. B. 1977 Effects of low concentrations of ethanol on the fluidity of spin-labeled erythrocyte and brain membranes Molecular Pharmacology 13 3 435 441 0002-6895x
  12. 12. Chin J. H. Goldstein D. B. 1977 Drug tolerance in biomembranes Science 196 4290 684 685 0036-8075
  13. 13. Chin J. H. Parson L. M. Goldstein D. B. 1978 Increased cholesterol content of erythrocyte and brain membranes in ethanol-tolerant mice BiochimicaetBiophysicaActa 513 3 358 363 0270-9139
  14. 14. Coll O. Colell A. Garcia-Ruiz C. Kaplowitz N. Fernandez-Checa J. C. 2003 Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion Hepatology 38 3 692 702 0270-9139
  15. 15. Colell A. Garcia-Ruiz C. Morales A. Ballestta A. Ookhtens M. Rodés J. Kaplowitz N. Fernandez-Checa J. C. 1997 Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: Effect of membrane physical properties and S-adenosyl-L-Methionine Hepatology 26 3 699 708 0270-9139
  16. 16. Colell A. Coll O. Garcia-Ruiz C. Paris R. Tiribelli C. Kaplowitz N. Fernandez-Checa J. C. 2001 Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione Hepatology 34 5 964 971 0270-9139
  17. 17. Corpechot C. Chazouillères O. . Poupon R. 2011 Early primary biliary cirrhosis : biochemical response to treatment and prediction of long-term outcome Journal of Hepatology 0168-8278
  18. 18. Cunningham C. C. Bottenus R. E. Spach P. I. . Rudel L. L. 1983 Ethanol-induced changes in liver microsomes and mitochondria from the monkey, Macacafascicularis Alcoholism : Clinical and Experimental Research 7 4 424 430 0145-6008
  19. 19. Dai Q. Zhang J. Pruett S. B. 2005 Ethanol alters cellular activation and CD14 partitioning in lipid rafts Biochemical and Biophysical Research Communications 332 1 37 42 0000-6291
  20. 20. De Minicis S. Brenner D. A. 2008 Oxidative stress in alcholoc liver disease : role of NADPH oxidase complex Journal of Gastroenterology and Hepatology 23 S98 S103 0815-9319
  21. 21. Dolganiuc A. Bakis G. Kodys K. Mandrekar P. . Szabo G. 2006 Acute ethanol treatment modulates toll-like receptor-4 association with lipid rafts Alcoholism : Clinical and Experimental Research 30 1 76 85 0145-6008
  22. 22. Duraisamy Y. Lambert D. O’Neill C. A. . Padfield P. J. 2007 Differential incorporation of docosahexaenoic acid into distinct cholesterol-rich membrane raft domains Biochemical and Biophysical Research Communications 360 4 885 890 0000-6291
  23. 23. Escriba P. V. 2006 Membrane-lipid therapy : a new approach in molecular medicine. Trends in Molecular Medecine 12 1 34 43 1471-4914
  24. 24. Fan Y. Y. Ly L. H. Barhoumi R. Mc Murray D. N. Chapkin R. S. 2004 Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. Journal of Immunology 173 10 6151 6160 0022-1767
  25. 25. Fernandez-Lizarbe S. Pascual M. Gascon M. S. Blanco A. . Guerri C. 2008 Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages Molecular Immunology 45 7 2007 2016 0161-5890
  26. 26. Fitzgerald K. A. Rowe R. C. . Golenbock D. T. 2004 Endotoxin recognition and signal transduction by the TLR4/MD2-complex Microbes and Infection 6 15 1361 1367 1286-4579
  27. 27. Gabbita S. P. Subramaniam R. Allouch F. Carney J. M. Butterfield D. A. 1998 Effects of mitochondrial respiratory stimulation on membrane lipids and proteins : an electron paramagnetic resonance investigation. BiochimicaetBiophysicaActa, 1372 2 163 173 0006-3002
  28. 28. Gao B. Deki E. Benner D. A. Frideman S. Cohen J. I. Nagy L. Szabo G. . Zakhari S. 2011 Innate immunity in alcoholic liver disease American Journal of Physiology 300 4 G516 G525 0193-1857
  29. 29. Ghare S. Patil M. Hote P. Suttles J. Mc Clain C. Barve S. Joshi-Barve S. 2011 Ethanol inhibits lipid raft-mediated TCR signaling and IL-2 expression: potential mechanism of alcohol-induced immune suppression. Alcoholism: Clinical and Experimental Research 35 8 1 10 0145-6008
  30. 30. Goldstein D.B 1984 The effects of drugs on membrane fluidity Annual Review of Pharmacology and Toxicology 24 43 64 0362-1642
  31. 31. Goldstein D. B. 1987 Ethanol-induced adaptation in biological membranes Annals of the New York Academy of Sciences 492 103 111 0077-8923
  32. 32. Güldütuna S. Zimmer G. Imhof M. Bhatti S. You T. . Leuschner U. 1993 Molecular aspects of membrane stabilization by ursodeoxycholate Gastroenterology 104 6 1736 1744 0016-5085
  33. 33. Gurtovenko A. A. Anwar J. 2009 Interaction of ethanol with biological membranes : the formation of non-bilayer structures within the membrane interior and their significance. The Journal of Physical Chemistry B 113 7 1983 1992 1520-6106
  34. 34. Guttiérez-Ruiz M. C. Gomez J. L. Souza V. . Bucio L. 1995 Chronic and acute ethanol treatment modifies fluidity and composition in plasma membranes of a human hepatic cell line (WRL-68). Cell Biology and Toxicology 11 2 69 78 0742-2091
  35. 35. Harder T. . Engelhardt K. R. 2004 Membrane microdomains in lymphocytes- from lipid rafts to protein scaffolds Traffic 5 4 265 275 1600-0854
  36. 36. Ho C. Williams B. W. Kelly M. B. Stubbs C. D. 1994 Chronic ethanol intoxication induces adaptative changes in the membrane protein/lipid interface BiochimicaetBiophysicaActa 1189 7 135 142 0006-3002
  37. 37. Jain S. Thomas M. Kumar P. . Laloraya M. 1994 Appearance of homogeneous smecticmultilamellar microenvironments in biomembranes undergoing superoxide-initiated lipid peroxidation : lipid-dienyl radical acccumulation and fluidity management in lipid bilayers Biochemistry and Molecular Biology International, 33 5 853 862 1039-9712
  38. 38. Jeong W. I. . Gao B. 2008 Innate immunity and alcoholic liver fibrosis Journal of Gastroenterology and Hepatology 23 S112 S118 0815-9319
  39. 39. Johnson D. A. Lee N. M. Cooke R. . Loh H. H. 1979 Ethanol-induced fluidization of brain lipid bilayers : required presence of cholesterol in membranes for the expression of tolerance Molecular Pharmacology 15 1979 739 746 0002-6895x.
  40. 40. Lingwood D. Simons K. 2010 Lipid rafts as a membrane-organizing principle Science 237 46 50 0036-8075
  41. 41. Lluis J. M. Colell A. Garcia-Ruiz C. Kaplowitz N. Fernandez-Checa J. C. 2003 Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology 124 3 708 724 0016-5085
  42. 42. Lyon R. C. Goldstein D. B. 1983 Changes in synaptic membrane order associated with chronic ethanol treatment in mice. Molecular Pharmacology 23 1 86 91 0002-6895 x.
  43. 43. Marquês J. T. Viana A. S. De Almeida R. F. 2011 Ethanol effects on binary and ternary supported lipid bilayers with gel/fluid domains and lipid rafts.Biochimica and BiophysicaActa 1808 1 405 414 0036-3002
  44. 44. Mc Call D. Henderson G. I. Gray P. . Schenker S. 1989 Ethanol effects on active Na+ and K+ transport in cultured fetal rat hepatocytes. Biochemical Pharmacology 38 16 2593 2600 2593-2600
  45. 45. Mills P. R. Meier P. J. Boyer J. L. Gordon E. R. 1985 The effect of ethanol and calcium on fluid state of plasma membranes of rat hepatocytes Alcohol 2 1 153 156 0006-2952
  46. 46. Nanji A. A. Khettry U. . Sadrzadeh S. M. 1994 Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. P roceedings of the Society for Biology and Medicine 205 3 243 247 0037-9727
  47. 47. Nelson S. Kolls J. K. 2002 Alcohol, host defence and society Nature reviews. Immunology 2 3 205 209 1471-1733
  48. 48. Nourissat P. Travert M. Chevanne M. Tekpli X. Rebillard A. Le Moigne Müller G. Rissel M. Cillard J. Dimanche-Boitrel M. T. Lagadic-Gossmann D. . Sergent O. 2008 Ethanol induces oxidative stress in primary rat hepatocytes through the early involvement of lipid raft clustering Hepatology 47 1 59 70 0270-9139
  49. 49. Oliva L. Beaugé F. Choquart A. M. Guitaoui M. . Montet J. C. 1998 Ursodeoxycholate alleviates alcoholic fatty liver damage in rats. Alcoholism : Clinical and Experimental Research, 22 7 1538 1543 0145-6008
  50. 50. Parlesak A. Schäfer C. Schütz T. Bode J. C. . Bode C. 2000 Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease Journal of Hepatology 32 5 742 747 0168-8278
  51. 51. Parmahamsa M. Reddy K. R. Varadacharyulu N. 2004 Changes in composition and properties of erythrocyte membrane in chronic alcoholics Alcohol & Alcoholism 39 2 110 112 0735-0414
  52. 52. Pelletier G. Roulot D. Davion T. Masliah C. Causse X. Oberti F. Raabe J. J. Van Lemmens C. Labadie H. . Serfaty L.. 2003 A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis jaundice Hepatology 37 4 887 892 0270-9139
  53. 53. Pike L.J. 2003 Lipid rafts : bringing order to chaos Journal of Lipid Research 44 4 655 667 0022-2275
  54. 54. Polokoff M. A. Simon T. J. Harris A. Simon F. R. . Iwahashi 1985 Chronic ethanol increases liver plasma membrane fluidity Biochemistry 24 13 3114 3120 0006-2960
  55. 55. Ponnappa B. C. Waring A. J. Hoeck J. B. Rottenberg H. Rubin E. 1982 Chronic ethanol ingestion increases calcium uptake and resistance to molecular disordering by ethanol in liver microsomes. The Journal of Biological Chemistry 257 17 10141 10146 0021-9258
  56. 56. Poupon R. E. Lindor K. D. Pares A. Chazouilleres O. Poupon R. . Heathcote E. J. 2003 Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis Journal of Hepatology 39 1 1 12 16 0168-8278
  57. 57. Rebillard A. Tekpli X. Meurette O. Sergent O. Le Moigne-Muller G. Vernhet L. Gorria M. Chevanne M. Christmann M. Kaina B. Counillon L. Gulbins E. Lagadic-Gossmann D. . Dimanche-Boitrel M. T. 2007 Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Research 67 16 7865 7874 0008-5472
  58. 58. Remy-Kristensen A. Duportail G. Coupin G. . Kuhry J. G. 2000 The influence of microtubule integrity on plasma membrane fluidity in L929 cells.Molecular Membrane Biology 17 2 95 100 0968-7688
  59. 59. Rottenberg H. 1992 Liver cell membrane adaptation to chronic alcohol consumption In :Drug and Alcohol Abuse Reviews, Liver Pathology and Alcohol 2 91 115The humana Press, 978-0-89603-206-4 Totowa, New Jersey, USA.
  60. 60. Rubin E. . Rottenberg H. 1982 Ethanol-induced injury and adaptation in biological membranes. Federation Proceedings 41 8 2465 2471 0014-9446
  61. 61. Schachter D. 1984 Fluidity and function of hepatocyte plasma membranes Hepatology 4 1 140 151 0270-9139
  62. 62. Schmitz G. . Orso E. 2002 CD14 signaling in lipid rafts : new ligands and co-receptors, Current Opinion in Lipidology 13 5 513 521 0957-9672
  63. 63. Schüller A. Moscat J. Diez E. Fernandez-Checa C. Gavilanes F. G. . Muncio A. M. 1984 The fluidity of plasma membranes from ethanol-treated rat liver. Molecular and Cellular Biochemistry 64 1 89 95 0300-8177
  64. 64. Seki E. De Minicis S. Osterreicher C. H. Kluwe J. Osawa Y. Brenner D. A. . Schwabe R. F. 2007 T. L. R4. enhance T.G.F-beta signalling hepatic fibrosis. Nature Medicine 13 11 1324 1332 1078-8956
  65. 65. Seki E. Brenner D. A. 2008 Toll-like receptors and adaptator molecules in liver disease: update. Hepatology 48 1 322 335 0270-9139
  66. 66. Sergent O. Pereira M. Belhomme C. Chevane M. Huc L. . Lagadic-Gosmman D. 2005 Role for membrane fluidity in ethanol-induced oxidative stress in primary rat hepatocytes The Journal of Pharmacolgy and Experimental Therapeutics 313 1 104 111 0022-3665
  67. 67. Simons K. . Toomre D. 2000 Lipid rafts and signal transduction Nature Reviews. Molecular Cell Biology, 1 1 31 39 1471-0072
  68. 68. Singer S. J. Nicolson G. L. 1972 The fluid mosaic model of the structure of cell membranes.Science 175 23 720 731 0036-8075
  69. 69. Stubbs C. D. Williams D. B. Pryor C. L. Rubin E. 1988 Ethanol-induced modifications to membrane lipid structure : effect on phospholipase A2 membrane interactions Archives of Biochemistry and Biophysics 262 2 560 573 0003-9861
  70. 70. Stulnig T. M. Huber J. Leitinger N. Imre E. M. Angelisova P. Nowotny P. . Waldhausl W. 2001 Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition Journal of Biological Chemistry 276 37335 37340
  71. 71. Suh Y. G. Jeong W. I. 2011 Hepatic stellate cells and innate immunity in alcoholic liver disease World Journal of Gastroenterology 17 20 2543 2551 1007-9327
  72. 72. Subramaniam R. Roediger F. Jordan B. Mattson M. P. Keller J. N. Waeg G. Butterfield D. A. 1997 The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. Journal of Neurochemistry 69 3 1161 1169 0022-3042
  73. 73. Szabo G. 1999 Consequences of alcohol consumption on host defense.Alcohol and Alcoholism 34 6 830 841 0735-0414
  74. 74. Szabo G. Dolganiuc A. Dai Q. Pruett S. B. 2007 TLR4, ethanol and lipid rafts : a new mechanism of ethanol action with implications for other receptor-mediated effects. Journal of Immunology 178 3 1243 1249 0022-1767
  75. 75. Szabo G. . Bala S. 2010 Alcoholic liver disease and the gut-liver axis World Journal of Gastroenterology 16 11 1321 1329 1007-9327
  76. 76. Tarahosky Y. S. Muzafarov E. N. Kim Y. A. 2008 Rafts making and rafts braking : how plant flavonoids may control membrane heterogeneity Molecular and Cellular Biochemistry 314 1-2 65 71 0300-8177
  77. 77. Taraschi T. F. Wu A. Rubin E. 1985 Phospholipid spin probes measure the effects of ethanol on the molecular order of liver microsomes. Biochemistry 24 1985 7096 7101 0021-2960
  78. 78. Tekpli X. Holme J. A. Sergent O. . Lagadic-Gossmann D. 2011 Importance of plasma membrane dynamics in chemical-induced carcinogenesis Recent Patents on Anti-Cancer Drug Discovery 6 6 1574-8928
  79. 79. Triantafilou M. Miyake K. Golenbock D. T. . Triantafilou K. 2002 Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. Journal of Cell Science 115 Pt12 2603 2611 0021-9533
  80. 80. Valles S. L. Blanco A. M. Azorin I. Guasch R. Pascual M. Gomez-Lechon M. J. Renau-Piqueras J. . Guerri C. 2003 Chronic ethanol consumprion enhances interleukin-1 mediated signal transduction in rat liver and in cultured hepatocytes. Alcohol: Clinical and Experimental Research 27 12 1979 1986 0145-6008
  81. 81. Waring A. J. Rottenberg H. Ohnishi T. Rubin E. 1981 Membranes and phospholipids of liver mitochondria from chronic alcoholic rats are resistant to membrane disordering by ethanol Proceedings of the National Academy of Sciences of the United States of America 78 4 2582 2586 0027-8424
  82. 82. Wassal S. R. Stillwell W. 2009 Polyunsaturated fatty-acid-cholesterol interactions : domain formation in membranes. BiochimicaetBiophysicaActa, 1788 1 24 32 0006-3002
  83. 83. Wong S. W. Kwon M. J. Choi A. M. K. Kim H. P. Nakahira K. Hwang D. H. 2009 Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner Journal of Biological Chemistry 284 40 27384 27392 0021-9258
  84. 84. Wood W. G. Schroeder F. 1988 Membrane effects of ethanol : bulk lipid versus lipid domains Life Science 43 6 467 475 0024-3205
  85. 85. Wu D. . Cederbaum A. I. 2009 Oxidative stress and alcoholic liver disease Seminars in Liver Disease 29 2 141 154 0272-8087
  86. 86. Yamada S. . Lieber C. S. 1984 Decrease in microviscosity and cholesterol content of rat liver plasma membranes after chronic ethanol feeding. The Journal of Clinical Investigation 74 6 2285 2289 0021-9738
  87. 87. Yaqoob P. . Shaikh S. R. 2010 The nutritional and clinical significance of lipid rafts Current Opinion in Clinical Nutrition and Metabolic Care 13 2 156 166 1363-1950
  88. 88. Yoon Y. Török N. Krueger E. Oswald B. . Mc Niven M. A. 1998 Ethanol-induced alterations of the microtubule cytoskeleton in hepatocytes The American Journal of Physiology 274 4Pt1 G757 G766 0002-9513

Written By

Odile Sergent, Fatiha Djoudi-Aliche and Dominique Lagadic-Gossmann

Submitted: 17 February 2011 Published: 11 January 2012